| 영문 | host | 한글 | 숙주 |
|---|---|---|---|
| 설명 | 다른 생물(기생체)을 기생시켜, 영양을 공급하는 동물 또는 식물. 마지막의 수주를 종숙주, 발육의 도중에 기생하는 숙주를 중간 숙주라고 한다. 기생동물 중에는 숙주가 특정한 종일 때도 있고 또 많은 기생충과 같이그 발생단계에 따라 많은 종류의 숙주를 필요로 하는 것도 있다. 이 경우 애벌레가 기생하는 숙주를 중간숙주, 성체가 기생하는 숙주를 최종숙주라고 한다. 간질인 경우에는 물고동이 중간숙주이고, 소-양 등은 최종숙주가 된다. 기생식물에는 겨우살이와 같이 졸참나무 등을 숙주로 하여 스스로 광합성을 하면서도 숙주에게서 영양을 얻는 것과, 야고와 같이 생강 등의 뿌리를 숙주로 하여 숙주에게서만 영양을 의존하는 것이 있다. 기생생물에는 이 밖에도 생물의 사체나 그 분해중에 있는 것, 배출물 등을 숙주로 하는 것도 있다. |
||
| 영문 | graft versus host reaction | 한글 | 이식편대 숙주반응 |
|---|---|---|---|
| 설명 | 면역이란 자신의 것과 자신의 것이 아닌 것을 구분해서 자신의 것이 아닌 것을 공격하여 생물학적 활성을 없애거나 제거하는 것이다. 이 면역은 주로 혈액에 있는 세포에 의해서 이루어진다. 특히 림프구는 이 면역에 중추적인 역할을 하는 세포이다. 이식편대숙주반응이라는 것은 이식되어온 조직에 존재하는 타인의 혈구들이 숙주의 세포를 공격하는 것을 말한다. 즉 이식되어온 조직과 함께 들어온 혈구들이 이식을 받은 사람의 세포를 타인의 것으로 인지해서 공격하는 현상이다. 이것은 이식을 받은 사람의 면역상태가 정상적일 경우에는 일어나지 않는데 왜냐하면 면역상태가 정상일 경우에는 이식되어온 장기와 더불어 들어온 타인의 혈구들을 이식을 받은 사람의 혈구가 타인의 것으로 인지해서 공격을 하고 숫적으로 유리하여 모두 죽일 수가 있기 때문이다. |
||
| 영문 | muscle cell(=muscle fiber) | 한글 | 근육세포 |
|---|---|---|---|
| 설명 | 근육은 수의근(의식에 의해서 조절이 가능한 근육: 예를 들어 다리, 팔, 얼굴근육 등)과 불수의근(의식과 무관하게 조절하지 않아도 움직이는 근육: 예를 들어 심장근, 소화기관에 분포하는 근육 등)으로 나누어지며, 근육세포의 모양은 다음과 같다(수의근, 불수의근 외에 심장에 있는 심장근은 불수의근에 해당하지만 그 모양은 수의근과 같아 따로 분류한다).  |
||
| 영문 | white blood cell(WBC), leukocyte | 한글 | 백혈구 |
|---|---|---|---|
| 설명 | 혈액내에 골수구계세포와 림프계세포, 단핵구계세포를 모두 통틀어 말한다. 백혈구의 증가가 있으면 대개 감염이 있거나, 혹은 탈수현상이 있음을 의미한다. 또한 지나친 백혈구수의 감소는 인체내 면역기능이 떨어져 있음을 의미하며, 다른 질병에 의해 나타나는 이차적인 현상이 아닌지 꼭 진단을 받아보아야 한다. |
||
| 영문 | mast cell | 한글 | 비만 세포 |
|---|---|---|---|
| 설명 | 동물의 결합 조직 가운데 널리 분포하는 세포. 결합조직과 점막조직 내에 있는 호염기성 색소로 이염색성(metachromasia)을 나타내는 과립을 가진 방추형의 세포에 작은 둥근 핵을 가진다. 비만세포의 표면에는 IgE에 대한 수용체가 존재하며, 수용체에 결합한 IgE 분자들끼리 다가의 항원에 의해 서로 연결되면 비만세포 과립탈출 반응이 일어나, 히스타민, 세로토닌, 헤파린 등의 화학전달 물질이 방출되어, 즉시형 알레르기 반응 등의 증상을 일으킨다. 피부, 장막, 혈관 주위, 점막 주변에 있다. |
||
| MC | mass casualties; mast cell; Master of Surgery [Lat. Magister Chirurgiae]; maximum concentration; Med... |
|---|---|
| ACC | accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst... |
| HCR | heme-controlled repressor; host-cell reactivation; hysterical conversion reaction |
| GC | ganglion cell; gas chromatography; general circulation; general closure; general condition; generali... |
| GVHD | Graft-Versus-Host Disease; 식대주 질환 |
| HCR | Host cell reactivation |
|---|---|
| AGVHD | Acute graft-versus-host disease |
| aGVHD | Acute graft-vs.-host disease |
| cGVHD | Chronic graft versus host disease |
| cGVHD | Chronic graft-vs.-host disease |
| host cell | A cell which has been infected by a virus is known as the host cell of that virus. A cell which is used in lab techniques such as DNA cloning to receive, maintain, and allow the reproduction of recombinant DNA cloning vectors. The DNA introduced with the vector is replicated whenever the cell divides and the recombinant proteins encoded for by the plasmid are reproduced in large quantities. (13 Nov 1997) |
|---|
| accidental host | One that harbors an organism which usually does not infect it. (05 Mar 2000) |
|---|---|
| amplifier host | A host in which infectious agents multiply rapidly to high levels, providing an important source of infection for vectors in vector-borne diseases. (05 Mar 2000) |
| parasite-host ecosystem | Complex of all parasite species and individuals associated with a specific host. Synonym: parasite-host ecosystem. Origin: parasite + G. Koinos, common, together (05 Mar 2000) |
| paratenic host | An intermediate host in which no development of the parasite occurs, although its presence may be required as an essential link in the completion of the parasite's life cycle; e.g., the successive fish host's that carry the plerocercoid of Diphyllobothrium latum, the broad fish tapeworm, to larger food fish eventually eaten by man or other final host's. Synonym: transport host. (05 Mar 2000) |
| reservoir host | The host of an infection in which the infectious agent multiplies and/or develops, and upon which the agent is dependent for survival in nature; the host essential for the maintenance of the infection during times when active transmission is not occurring. (05 Mar 2000) |
| graft-versus-host disease | <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue. When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage. The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign. The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin. Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel. Synonym: GVH disease. Acronym: GVHD (20 Sep 2002) |
| graft-versus-host reaction | <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue. When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage. The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign. The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin. Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel. Synonym: GVH disease. Acronym: GVHD (20 Sep 2002) |
| graft-versus-host response | <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue. When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage. The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign. The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin. Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel. Synonym: GVH disease. Acronym: GVHD (20 Sep 2002) |
| cutaneous graft versus host reaction | An acute erythematous maculopapular reaction with bulla formation in the most severe cases; chronic changes may resemble lichen planus or scleroderma. (05 Mar 2000) |
| secondary host | <epidemiology> See vector. (05 Dec 1998) |
| host | An organism that is infected with or is fed upon by a parasitic or pathogenic organism (for example, a virus, nematode, fungus). The term can also be applied, loosely, to a plant supporting an epiphyte. (09 Oct 1997) |
| host-parasite relations | The interactions between two organisms, one of which lives at the expense of the other. (12 Dec 1998) |
| host range | The range of host species or cell types which a particular virus, bacteria, or parasite is able to infect or parasitise. (09 Oct 1997) |
| host range mutant | A mutant of phage or animal virus that grows normally in one of its host cells, but has lost the ability to grow in cells of a second host type. (18 Nov 1997) |
| host restriction-modification | A bacterial system where the bacterium is able to destroy invading DNA from a bacteriophage (virus which infects bacteria) while at the same time preventing the destruction of their own DNA. The phage DNA is cleaved by a restriction enzyme made by the bacterium, the bacterial DNA is modified (usually with methylation) so that the enzyme will not destroy it. (09 Oct 1997) |
Synonyms : C1 Host Cell Factor, Cell Proliferation Factor HCF
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|